0001193125-19-235280.txt : 20190830 0001193125-19-235280.hdr.sgml : 20190830 20190830160603 ACCESSION NUMBER: 0001193125-19-235280 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20190827 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20190830 DATE AS OF CHANGE: 20190830 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Horizon Therapeutics Public Ltd Co CENTRAL INDEX KEY: 0001492426 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35238 FILM NUMBER: 191069605 BUSINESS ADDRESS: STREET 1: CONNAUGHT HOUSE, 1ST FLOOR STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN STATE: L2 ZIP: 4 BUSINESS PHONE: 011-353-1-772-2100 MAIL ADDRESS: STREET 1: CONNAUGHT HOUSE, 1ST FLOOR STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN STATE: L2 ZIP: 4 FORMER COMPANY: FORMER CONFORMED NAME: Horizon Pharma plc DATE OF NAME CHANGE: 20140919 FORMER COMPANY: FORMER CONFORMED NAME: HORIZON PHARMA, INC. DATE OF NAME CHANGE: 20100520 8-K 1 d759891d8k.htm 8-K 8-K
Horizon Therapeutics Public Ltd Co NASDAQ 00-0000000 false 0001492426 0001492426 2019-08-27 2019-08-27

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 27, 2019

 

Horizon Therapeutics Public Limited Company

(Exact name of registrant as specified in its charter)

 

Ireland

  

001-35238

 

Not Applicable

(State or other jurisdiction

of incorporation)

  

(Commission

File No.)

  

(IRS Employer

Identification No.)

Connaught House, 1st Floor, 1 Burlington Road, Dublin 4, D04 C5Y6, Ireland

(Address of principal executive offices)

Registrant’s telephone number, including area code: 011-353-1-772-2100

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:    

Title of each class

  

Trading

Symbol(s)

  

Name of each exchange

on which registered

Ordinary shares, nominal value $0.0001 per share

  

HZNP

  

The Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(b) On August 27, 2019, Robert Carey, our Executive Vice President, Chief Business Officer, informed us that he will be retiring effective October 1, 2019. In connection with his retirement, and in exchange for a release of claims in favor of the Company, we agreed to provide severance benefits to Mr. Carey consisting of (i) 15 months salary continuation and continuation of health benefits, (ii) continued eligibility for his annual 2019 cash bonus based on performance against pre-established goals, (iii) an amendment to his existing stock options to extend the exercise period through the term of the options, (iv) continued vesting of his restricted stock units and performance stock units (contingent upon meeting the pre-established performance metrics), and (v) continued vesting and payment of his existing cash long-term incentive plan awards.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: August 30, 2019

  

 

HORIZON Therapeutics PUBLIC LIMITED COMPANY

             

  

 

By:

  

/s/ Paul W. Hoelscher

  

 

 

Paul W. Hoelscher

  

 

 

Executive Vice President and Chief Financial Officer

 EX-101.SCH 2 hznp-20190827.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 3 hznp-20190827_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Entity Registrant Name Entity Registrant Name Security Exchange Name Security Exchange Name Entity Tax Identification Number Entity Tax Identification Number Local Phone Number Local Phone Number Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Document Type Document Type Document Fiscal Year Focus Document Fiscal Year Focus Document Period End Date Document Period End Date Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity File Number Entity File Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, City or Town Entity Address, City or Town Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Address, Country Entity Address, Country City Area Code City Area Code Written Communications Written Communications Soliciting Material Soliciting Material Pre-commencement Tender Offer Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security Title of 12(b) Security Trading Symbol Trading Symbol Entity Emerging Growth Company Entity Emerging Growth Company EX-101.PRE 4 hznp-20190827_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 5 d759891d8k_htm.xml IDEA: XBRL DOCUMENT 0001492426 2019-08-27 2019-08-27 Horizon Therapeutics Public Ltd Co NASDAQ 00-0000000 false 0001492426 8-K 2019-08-27 L2 001-35238 Connaught House, 1st Floor 1 Burlington Road Dublin 4 D04 C5Y6 IE 011 353-1-772-2100 false false false false Ordinary shares, nominal value $0.0001 per share HZNP false XML 6 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 7 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} ZIP 8 0001193125-19-235280-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-19-235280-xbrl.zip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htm IDEA: XBRL DOCUMENT v3.19.2
Document and Entity Information
Aug. 27, 2019
Cover [Abstract]  
Entity Registrant Name Horizon Therapeutics Public Ltd Co
Security Exchange Name NASDAQ
Entity Tax Identification Number 00-0000000
Local Phone Number 353-1-772-2100
Amendment Flag false
Entity Central Index Key 0001492426
Document Type 8-K
Document Period End Date Aug. 27, 2019
Entity Incorporation, State or Country Code L2
Entity File Number 001-35238
Entity Address, Address Line One Connaught House, 1st Floor
Entity Address, Address Line Two 1 Burlington Road
Entity Address, City or Town Dublin 4
Entity Address, Postal Zip Code D04 C5Y6
Entity Address, Country IE
City Area Code 011
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Ordinary shares, nominal value $0.0001 per share
Trading Symbol HZNP
Entity Emerging Growth Company false
EXCEL 12 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.2 html 1 97 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.horizonoharma.com//20190827/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports d759891d8k.htm hznp-20190827.xsd hznp-20190827_lab.xml hznp-20190827_pre.xml http://xbrl.sec.gov/dei/2019-01-31 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d759891d8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "d759891d8k.htm" ] }, "labelLink": { "local": [ "hznp-20190827_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "hznp-20190827_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "hznp-20190827.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd", "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd" ] } }, "elementCount": 25, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 5, "total": 5 }, "keyCustom": 0, "keyStandard": 97, "memberCustom": 0, "memberStandard": 0, "nsprefix": "hznp", "nsuri": "http://www.horizonoharma.com/20190827", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "span", "p", "div", "body", "html" ], "baseRef": "d759891d8k.htm", "contextRef": "duration_2019-08-27_to_2019-08-27", "decimals": null, "first": true, "lang": "en-US", "name": "dei:LocalPhoneNumber", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "role": "http://www.horizonoharma.com//20190827/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "div", "body", "html" ], "baseRef": "d759891d8k.htm", "contextRef": "duration_2019-08-27_to_2019-08-27", "decimals": null, "first": true, "lang": "en-US", "name": "dei:LocalPhoneNumber", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com//20190827/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com//20190827/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com//20190827/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com//20190827/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com//20190827/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com//20190827/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com//20190827/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com//20190827/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country", "terseLabel": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com//20190827/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com//20190827/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com//20190827/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com//20190827/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com//20190827/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com//20190827/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com//20190827/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com//20190827/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com//20190827/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com//20190827/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com//20190827/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com//20190827/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com//20190827/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com//20190827/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com//20190827/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.horizonoharma.com//20190827/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" }